Unlock stock picks and a broker-level newsfeed that powers Wall Street.
7.61
-0.32
(-4.04%)
At close: April 1 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | -0.42 | -0.39 | -1.4 | -0.71 |
| Low Estimate | -0.73 | -0.71 | -2.75 | -2.66 |
| High Estimate | -0.28 | -0.26 | -0.75 | 0.34 |
| Year Ago EPS | -0.72 | -0.05 | -1.02 | -1.4 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 9 |
| Avg. Estimate | 31.34M | 37.49M | 161.91M | 274.59M |
| Low Estimate | 25M | 31.5M | 135.5M | 203.3M |
| High Estimate | 34.75M | 41.57M | 187.17M | 325M |
| Year Ago Sales | -- | 8.19M | 131.16M | 161.91M |
| Sales Growth (year/est) | 0.00% | 357.59% | 23.44% | 69.60% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.66 | -0.59 | -0.25 | -0.35 |
| EPS Actual | -0.72 | -0.05 | 0.38 | -0.63 |
| Difference | -0.06 | 0.54 | 0.63 | -0.28 |
| Surprise % | -9.33% | 91.48% | 249.34% | -80.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.42 | -0.39 | -1.4 | -0.71 |
| 7 Days Ago | -0.42 | -0.39 | -1.4 | -0.55 |
| 30 Days Ago | -0.33 | -0.31 | -1.02 | -0.04 |
| 60 Days Ago | -0.34 | -0.29 | -1.14 | -0.17 |
| 90 Days Ago | -0.34 | -0.29 | -1.12 | -0.17 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | -- |
| Up Last 30 Days | -- | 1 | 2 | 2 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | 2 | 6 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DAWN | 42.20% | -686.28% | -37.31% | 49.39% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Buy to Buy | 3/25/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 3/5/2025 |
| Reiterates | Wedbush: Outperform to Outperform | 2/26/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/26/2025 |
| Reiterates | Needham: Buy to Buy | 2/26/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/10/2025 |
Related Tickers
SWTX SpringWorks Therapeutics, Inc.
41.88
-5.10%
PDSB PDS Biotechnology Corporation
1.0800
-9.24%
SNDX Syndax Pharmaceuticals, Inc.
12.01
-2.24%
RVMD Revolution Medicines, Inc.
33.62
-4.92%
IDYA IDEAYA Biosciences, Inc.
14.77
-9.83%
TARS Tarsus Pharmaceuticals, Inc.
48.92
-4.77%
CYTK Cytokinetics, Incorporated
37.50
-6.69%
BCYC Bicycle Therapeutics plc
7.85
-7.54%
PHAT Phathom Pharmaceuticals, Inc.
5.12
-18.34%
JANX Janux Therapeutics, Inc.
26.81
-0.70%